Emergency treatment of fluorouracil overdose

Emergency treatment of fluorouracil overdose refers to the urgent clinical management required after an adult or pediatric cancer patient receives an excessive dose or rapid infusion of the antimetabolite chemotherapy agent fluorouracil Uncontrolled fluorouracil exposure leads to profound systemic cytotoxicity, critically impairing rapidly dividing tissues and vital organs

Emergency treatment of fluorouracil overdose refers to the urgent clinical management required after an adult or pediatric cancer patient receives an excessive dose or rapid infusion of the antimetabolite chemotherapy agent fluorouracil This medical emergency also encompasses patients who develop early-onset, life-threatening toxicities—often exacerbated by dihydropyrimidine dehydrogenase deficiency—following systemic fluorouracil administration Defining pathophysiologic manifestations include s...

Emergency treatment of fluorouracil overdose refers to the urgent clinical management required after an adult or pediatric cancer patient receives an excessive dose or rapid infusion of the antimetabolite chemotherapy agent fluorouracil

This medical emergency also encompasses patients who develop early-onset, life-threatening toxicities—often exacerbated by dihydropyrimidine dehydrogenase deficiency—following systemic fluorouracil administration

This medical emergency also encompasses patients who develop early-onset, life-threatening toxicities—often exacerbated by dihydropyrimidine dehydrogenase deficiency—following systemic fluorouracil administration

Uncontrolled fluorouracil exposure leads to profound systemic cytotoxicity, critically impairing rapidly dividing tissues and vital organs Defining pathophysiologic manifestations include severe myelosuppression, extensive gastrointestinal mucositis and ulceration, acute neurotoxicity, cardiovascular collapse, and potential multi-organ failure

Uncontrolled fluorouracil exposure leads to profound systemic cytotoxicity, critically impairing rapidly dividing tissues and vital organs

Defining pathophysiologic manifestations include severe myelosuppression, extensive gastrointestinal mucositis and ulceration, acute neurotoxicity, cardiovascular collapse, and potential multi-organ failure